Literature DB >> 15238889

Surgical techniques for pancreatic cancer.

A Nakeeb1, K D Lillemoe, J L Grosfeld.   

Abstract

Surgical resection of pancreatic adenocarcinoma offers the only chance for long-term cure. Over the past 2 decades significant advances have been made in both the surgical techniques and the perioperative care of patients with pancreatic cancer. The operative management of pancreatic cancer involving the head, neck, and uncinate process consists of 2 phases: first, assessing tumor resectability and then, if the tumor is resectable, completing a pancreaticoduodenectomy and restoring gastrointestinal continuity. In this article, we describe our current techniques for resection of pancreatic cancer, review operative palliation for unresectable cancer, and discuss several controversies in the operative management of pancreatic cancer including: 1) the role of extended lymphadenectomy, 2) pylorus preservation and 3) pancreaticojejunostomy versus pancreaticogastrostomy for pancreatic duct reconstruction.

Entities:  

Mesh:

Year:  2004        PMID: 15238889

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  5 in total

1.  Necrosis and angioinvasion predict adverse outcome in pancreatic neuroendocrine tumors after curative surgical resection: results of a single-center series.

Authors:  Resit Demir; Johann Pohl; Abbas Agaimy; Georgios Peros; Aristoteles Perrakis; Susanne Merkel; Werner Hohenberger; Peter Klein
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

2.  Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen W Behrman; Edgar Ben-Josef; Al B Benson; Ephraim S Casper; Steven J Cohen; Brian Czito; Joshua D I Ellenhorn; William G Hawkins; Joseph Herman; John P Hoffman; Andrew Ko; Srinadh Komanduri; Albert Koong; Wen Wee Ma; Mokenge P Malafa; Nipun B Merchant; Sean J Mulvihill; Peter Muscarella; Eric K Nakakura; Jorge Obando; Martha B Pitman; Aaron R Sasson; Anitra Tally; Sarah P Thayer; Samuel Whiting; Robert A Wolff; Brian M Wolpin; Deborah A Freedman-Cass; Dorothy A Shead
Journal:  J Natl Compr Canc Netw       Date:  2012-06-01       Impact factor: 11.908

3.  Pancreatic cancer survival in central and northern Denmark from 1998 through 2009: a population-based cohort study.

Authors:  Deirdre P Cronin-Fenton; Rune Erichsen; Frank V Mortensen; Sarunas Dikinis; Mette Nørgaard; Jacob Jacobsen
Journal:  Clin Epidemiol       Date:  2011-07-20       Impact factor: 4.790

Review 4.  From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers.

Authors:  Ioannis D Kyrochristos; Georgios K Glantzounis; Demosthenes E Ziogas; Ioannis Gizas; Dimitrios Schizas; Efstathios G Lykoudis; Evangelos Felekouras; Anastasios Machairas; Christos Katsios; Theodoros Liakakos; William C Cho; Dimitrios H Roukos
Journal:  Int J Mol Sci       Date:  2017-01-18       Impact factor: 5.923

5.  Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma.

Authors:  Dao-Ning Liu; Ang Lv; Zhi-Hua Tian; Xiu-Yun Tian; Xiao-Ya Guan; Bin Dong; Min Zhao; Chun-Yi Hao
Journal:  Oncotarget       Date:  2017-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.